IRIS
MESSINA, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.727
EU - Europa 5.051
AS - Asia 1.436
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 4
AF - Africa 2
Totale 12.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.693
IE - Irlanda 1.670
CN - Cina 1.020
SE - Svezia 981
IT - Italia 567
DE - Germania 444
PL - Polonia 420
UA - Ucraina 317
FI - Finlandia 286
SG - Singapore 249
GB - Regno Unito 178
IN - India 93
FR - Francia 86
VN - Vietnam 38
BE - Belgio 37
CA - Canada 19
MX - Messico 14
CZ - Repubblica Ceca 13
NL - Olanda 13
RU - Federazione Russa 12
EU - Europa 11
IR - Iran 9
HK - Hong Kong 7
NZ - Nuova Zelanda 7
AT - Austria 6
AU - Australia 6
ES - Italia 4
KR - Corea 4
PT - Portogallo 4
TR - Turchia 4
PH - Filippine 3
BR - Brasile 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
HR - Croazia 2
NO - Norvegia 2
RO - Romania 2
SA - Arabia Saudita 2
A1 - Anonimo 1
CH - Svizzera 1
IL - Israele 1
JP - Giappone 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 12.245
Salva come PNG Salva come JPEG
Città #
Dublin 1.664
Chandler 1.064
Jacksonville 793
Nyköping 571
Beijing 479
Warsaw 420
Princeton 365
Medford 308
Ashburn 279
Cambridge 261
Des Moines 215
Ann Arbor 212
Dearborn 182
Messina 154
Singapore 149
Boardman 146
San Mateo 94
Lancaster 92
Shenyang 74
Wilmington 72
Jinan 70
Pune 70
Bremen 68
Rome 53
Nanjing 52
Woodbridge 44
New York 42
Dong Ket 38
Tianjin 38
Houston 37
Los Angeles 37
Brussels 34
Hebei 32
Ningbo 32
Zhengzhou 32
Hangzhou 29
Munich 23
Haikou 22
Taizhou 21
Nanchang 20
Lappeenranta 19
Norwalk 19
Guangzhou 17
Nürnberg 17
Seattle 16
Falls Church 15
Fuzhou 13
Helsinki 13
Palo Del Colle 13
Changsha 11
Jiaxing 11
Augusta 10
Milan 10
Taiyuan 10
Brno 9
Guadalupe 9
Leawood 9
Riposto 9
Hyderabad 8
London 8
Fort Worth 7
Hong Kong 7
Lanzhou 7
Ottawa 7
Paris 7
Tappahannock 7
Ardabil 6
Auburn Hills 6
Catania 6
Washington 6
Ciudad Benito Juárez 5
Clearwater 5
Fairfield 5
Hanover 5
Monmouth Junction 5
Toronto 5
Trecastagni 5
Amsterdam 4
Auckland 4
Bari 4
Bergamo 4
Mumbai 4
Prineville 4
Segrate 4
Shanghai 4
Vienna 4
Bologna 3
Caserta 3
Glasgow 3
Hefei 3
Hemel Hempstead 3
Kanpur 3
Mannheim 3
Mountain View 3
Napoli 3
Northampton 3
Nynäshamn 3
Piazza Armerina 3
Redwood City 3
Saint Petersburg 3
Totale 8.813
Salva come PNG Salva come JPEG
Nome #
Severe rhabdomyolysis in a patient with “Heat Stroke” 192
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 102
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 91
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 90
Hippo signaling pathway is altered in Duchenne muscular dystrophy 85
The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability. 83
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 78
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 78
Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study. 77
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 77
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 75
An observational study of functional abilities in infants, children, and adults with type 1 SMA 72
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 72
Histological effects of givinostat in boys with Duchenne muscular dystrophy 70
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 70
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 69
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 69
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 68
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 67
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 67
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 67
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 66
Effect of exercise on telomere length and telomere proteins expression in mdx mice 65
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 64
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 64
Pilot study of flavocoxid in ambulant DMD patients. 64
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 64
The 24-month PUL changes and steroids correlation. 63
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 63
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 63
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 63
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 62
EFFECT OF TREATMENT WITH PDTC AND IRFI 042 ON STRENGTH AND FATIGUE IN MDX MICE 61
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 60
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice 60
Pilot study of flavocoxid in ambulant DMD patients. 60
Pilot study of serial casting in muscular dystrophy patients. 60
Pilot study of serial casting of ankles in muscular dystrophy patients. 60
Nusinersen versus sham control in later-onset spinal muscular atrophy 60
Apoptosis and apoptosis-related proteins in thyroid myopathies 59
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 59
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 59
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 58
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 57
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 56
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 56
A comprehensive molecular approach in COLA6 related myopathies based on genomic sequencing, transcriptional analysis and array CGH. 55
Methods of treating Duchenne muscular dystrophy with flavonoids 55
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 55
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 55
Dystrophin gene and SHOX gene mutations in a child with Becker muscular dystrophy and short stature 54
Daily salbutamol in young patients with SMA type II. 54
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 54
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 54
Autonomic nervous system involvement in spinal muscular atrophy. 54
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 54
Genomic Variations Affecting Biological Effects of Statins 53
Severe rhabdomyolysis in a patient with “Heat Stroke” 53
ANT1 is reduced in sporadic inclusion body myositis. 53
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 53
Congenital form of distal spinal muscular atrophy affecting the lower limbs: a common condition in childhood. 52
Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations 52
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 52
Axial myopathy in myasthenia: a misleading cause of dropped head 51
Trattamento chirurgico delle scoliosi in pazienti affetti da distrofia muscolare di Duchenne. 51
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 51
Prevalence of congenital muscular dystrophy in Italy: a population study 51
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. 50
A new form of alpha-dystroglycanopathy associated with severe drug-resistant epilepsy and unusual EEG features 50
Protocollo diagnostico e terapia delle patologie neuromuscolari ereditarie in età evolutiva 50
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 50
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 50
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 50
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 50
POMT2 mutation in a patient with 'MEB-like' phenotype. 49
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx. 49
Seizure aggravation caused by antiepileptic drugs in a patient with muscle-eye-brain disease. 49
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 49
Factors predicting survival in ALS: a multicenter Italian study 49
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 49
Nuovi meccanismi nelle distrofie muscolari: i difetti di glicosilazione dell’ α-distroglicano. 48
Dual-echo dual flip angle gradient-echo MRI technique for quantification of muscle fat fraction in Duchenne muscular dystrophy: a new valuable outcome measure. 48
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 48
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy 48
Development of an academic disease registry for spinal muscular atrophy 48
Alexithymia, burden and resilience in ALS’ caregivers 48
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 47
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 47
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 47
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 47
Pilot study of flavocoxid in ambulant DMD patients. 47
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 47
Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. 46
Caratterizzazione molecolare nelle miopatie da COLA6 mediante sequenziamento estensivo, analisi trascrizionale ed array CGH. 46
Conceptualizing the relations between metacognition and executive functions in Amyotrophic Lateral Sclerosis (ALS) patients’ caregivers. A preliminary study 46
Effect of treatment with PDTC and IRFI 042 on strenght and fatigue in mdx mice 45
Feeding problems and malnutrition in Spinal Muscular Atrophy type II. 45
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 45
Limb-girdle myasthenia: clinical, electrophysiological and morphological features in familial and autoimmune cases 45
Nuclear factor-kappaB, mitogen-activated protein kinases and cyclooxygenase/5-lipoxygenase pathway inhibition by flavocoxid improves muscle function and morphology in mdx mice: a comparison study with methylprednisolone. 45
Totale 5.938
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.661 0 0 7 95 23 205 198 189 72 399 377 96
2020/20211.874 152 63 411 88 327 128 91 165 53 200 106 90
2021/20221.696 9 123 13 113 97 14 126 72 51 119 211 748
2022/20234.412 392 321 161 311 381 388 29 237 2.010 21 122 39
2023/20241.125 84 208 73 101 115 216 48 31 16 43 29 161
2024/2025249 98 76 75 0 0 0 0 0 0 0 0 0
Totale 12.794